CVRX
Price
$12.11
Change
+$0.39 (+3.33%)
Updated
Dec 20, 04:59 PM (EDT)
31 days until earnings call
ICAD
Price
$1.86
Change
+$0.03 (+1.64%)
Updated
Dec 23, 10:41 AM (EDT)
65 days until earnings call
Ad is loading...

CVRX vs ICAD

Header iconCVRX vs ICAD Comparison
Open Charts CVRX vs ICADBanner chart's image
CVRx
Price$12.11
Change+$0.39 (+3.33%)
Volume$5.03K
CapitalizationN/A
iCAD
Price$1.86
Change+$0.03 (+1.64%)
Volume$10.41K
CapitalizationN/A
CVRX vs ICAD Comparison Chart
Loading...
CVRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVRX vs. ICAD commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVRX is a Hold and ICAD is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (CVRX: $12.11 vs. ICAD: $1.83)
Brand notoriety: CVRX and ICAD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CVRX: 91% vs. ICAD: 64%
Market capitalization -- CVRX: $381.09M vs. ICAD: $42.43M
CVRX [@Medical Specialties] is valued at $381.09M. ICAD’s [@Medical Specialties] market capitalization is $42.43M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVRX’s FA Score shows that 0 FA rating(s) are green whileICAD’s FA Score has 0 green FA rating(s).

  • CVRX’s FA Score: 0 green, 5 red.
  • ICAD’s FA Score: 0 green, 5 red.
According to our system of comparison, ICAD is a better buy in the long-term than CVRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVRX’s TA Score shows that 5 TA indicator(s) are bullish while ICAD’s TA Score has 6 bullish TA indicator(s).

  • CVRX’s TA Score: 5 bullish, 4 bearish.
  • ICAD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ICAD is a better buy in the short-term than CVRX.

Price Growth

CVRX (@Medical Specialties) experienced а -5.61% price change this week, while ICAD (@Medical Specialties) price change was -6.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

CVRX is expected to report earnings on Jan 23, 2025.

ICAD is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVRX($381M) has a higher market cap than ICAD($42.4M). ICAD YTD gains are higher at: 3.390 vs. CVRX (-61.482). ICAD has higher annual earnings (EBITDA): -12.18M vs. CVRX (-38.73M). CVRX has more cash in the bank: 90.6M vs. ICAD (19M). ICAD has less debt than CVRX: ICAD (514K) vs CVRX (30.6M). CVRX has higher revenues than ICAD: CVRX (39.3M) vs ICAD (25.4M).
CVRXICADCVRX / ICAD
Capitalization381M42.4M899%
EBITDA-38.73M-12.18M318%
Gain YTD-61.4823.390-1,814%
P/E Ratio0.18N/A-
Revenue39.3M25.4M155%
Total Cash90.6M19M477%
Total Debt30.6M514K5,953%
FUNDAMENTALS RATINGS
ICAD: Fundamental Ratings
ICAD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVRXICAD
RSI
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 7 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 5 days ago
70%
View a ticker or compare two or three
Ad is loading...
CVRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPRAX24.490.31
+1.29%
PGIM Quant Solutions Mid-Cap Val A
BEGIX21.880.25
+1.16%
Sterling Capital Equity Income Instl
TIGRX15.210.17
+1.13%
Nuveen Core Equity R6
GDLFX17.940.12
+0.67%
Gotham Defensive Long 500 Institutional
CRSSX10.15-0.02
-0.20%
Catholic Rspnsbl Invstmnts Small-Cap Ins

CVRX and

Correlation & Price change

A.I.dvisor tells us that CVRX and LIVN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVRX and LIVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVRX
1D Price
Change %
CVRX100%
+3.33%
LIVN - CVRX
29%
Poorly correlated
+0.21%
AZTA - CVRX
28%
Poorly correlated
+1.88%
ICAD - CVRX
27%
Poorly correlated
+3.39%
ANIK - CVRX
27%
Poorly correlated
-0.12%
TMDX - CVRX
27%
Poorly correlated
+1.93%
More

ICAD and

Correlation & Price change

A.I.dvisor tells us that ICAD and HAE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ICAD and HAE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICAD
1D Price
Change %
ICAD100%
+3.39%
HAE - ICAD
32%
Poorly correlated
-1.90%
VMD - ICAD
29%
Poorly correlated
-0.50%
NARI - ICAD
29%
Poorly correlated
+1.91%
HYPR - ICAD
29%
Poorly correlated
-4.83%
CVRX - ICAD
27%
Poorly correlated
+3.33%
More